Search Ontology:
ChEBI
MCC950
- Term ID
- CHEBI:231684
- Synonyms
-
- CP-456,773
- CP-456773
- CRID3
- cytokine release inhibitory drug 3
- MCC 950
- MCC-950
- N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
- Definition
- A member of the class of s-indacenes that is 1,2,3,5,6,7-hexahydro-s-indacene substituted by a ({[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonyl}carbamoyl)amino group at position 4. It is a potent and selective NLRP3 inhibitor.
- References
-
- CAS:210826-40-7
- PMID:32956781
- PMID:35579347
- PMID:36562558
- PMID:36562561
- PMID:37150865
- PMID:37515181
- PMID:37591025
- PMID:37602308
- PMID:37702910
- PMID:37858713
- PMID:37958819
- PMID:38039716
- PMID:38040385
- PMID:38114914
- PMID:38240215
- PMID:38269433
- PMID:38319525
- PMID:38338456
- PMID:38340397
- PMID:38460298
- PMID:38509779
- PMID:38519142
- PMID:38692345
- PMID:38752538
- PMID:38797898
- PMID:38902941
- PMID:39003648
- PMID:39121559
- PMID:39180246
- PMID:39183455
- PMID:39217887
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from MCC950
Phenotype where environments contain MCC950
Phenotype modified by environments containing MCC950
Human Disease Model